MannKind Corp (MNKD)
4.09
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 11:13
MannKind Revenue (Quarterly): 58.47M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.47M |
| September 30, 2023 | 51.25M |
| June 30, 2023 | 48.61M |
| March 31, 2023 | 40.63M |
| December 31, 2022 | 36.06M |
| September 30, 2022 | 32.82M |
| June 30, 2022 | 18.89M |
| March 31, 2022 | 11.99M |
| December 31, 2021 | 12.52M |
| September 30, 2021 | 22.21M |
| June 30, 2021 | 23.28M |
| March 31, 2021 | 17.44M |
| December 31, 2020 | 18.44M |
| September 30, 2020 | 15.35M |
| June 30, 2020 | 15.11M |
| March 31, 2020 | 16.24M |
| December 31, 2019 | 15.99M |
| September 30, 2019 | 14.60M |
| June 30, 2019 | 15.00M |
| March 31, 2019 | 17.45M |
| December 31, 2018 | 16.03M |
| September 30, 2018 | 4.469M |
| June 30, 2018 | 3.893M |
| March 31, 2018 | 3.465M |
| December 31, 2017 | 4.53M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.043M |
| June 30, 2017 | 2.163M |
| March 31, 2017 | 3.009M |
| December 31, 2016 | 12.40M |
| September 30, 2016 | 162.35M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 0.035M |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
11.99M
Minimum
Mar 2022
58.47M
Maximum
Dec 2023
25.52M
Average
18.44M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.401M |
| Total Expenses (Quarterly) | 47.84M |
| EPS Diluted (Quarterly) | 0.01 |
| Enterprise Value | 1.080B |
| Gross Profit Margin (Quarterly) | 69.10% |
| Profit Margin (Quarterly) | 2.40% |
| Earnings Yield | -0.98% |
| Operating Earnings Yield | 0.92% |
| Normalized Earnings Yield | -0.8305 |